Back to Results
First PageMeta Content
AstraZeneca / Pharmaceutical industry / Influenza vaccines / Novartis / Influenza / MedImmune / FluMist / Influenza research / Biomedical Advanced Research and Development Authority / Vaccination / Vaccines / Medicine


Microsoft Word - ASPA_0420_20120615_ASPR_PR_Countermeasures_Fact_Sheet_D_v02 - Update.docx
Add to Reading List

Document Date: 2014-03-21 09:23:52


Open Document

File Size: 249,48 KB

Share Result on Facebook

City

Cambridge / /

Company

Novartis Vaccines and Diagnostics / Novartis / /

Country

United States / /

Currency

USD / /

Facility

Duke University of Durham / Holly Springs facility / North Carolina State University of Raleigh / ADVANCED DEVELOPMENT AND MANUFACTURING Center / /

IndustryTerm

pharmaceutical product development / manufacturing facilities / product development core services / workforce training program / manufacturing core services / /

MedicalCondition

demic influenza / pandemic influenza / infectious diseases / emerging infectious disease / influenza / /

Organization

Duke University / FDA / FOR INNOVATION IN ADVANCED DEVELOPMENT AND MANUFACTURING Center / U.S. government / North Carolina State University / CENTERS FOR INNOVATION IN ADVANCED DEVELOPMENT AND MANUFACTURING Center / /

Position

Private / /

ProvinceOrState

North Carolina / /

SocialTag